We are live on
!
Find out more
NVPX
Norwest Venture Partners XI Portfolio holdings
AUM
$32.1M
1-Year Est. Return
15.68%
This Fund
S&P 500
This Quarter
Est. Return
+37.9%
1 Year Est. Return
+15.68%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$47.3M
(+30%)
Cap. Flow
+$595K
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
APIC
Apigee Corporation Common Stock
APIC
|
+$6.48M |
Top Sells
| 1 |
XENT
Intersect ENT, Inc
XENT
|
+$5.88M |
Sector Composition
| 1 | Technology | 60.43% |
Similar funds
AI
MCG
M
CCCPI
CRM
MTB
RA
SC
Norwest Venture Partners XI's Q2 2015 Portfolio in Review
As of Q2 2015, Norwest Venture Partners XI held 4 positions worth $205M, up 30% from $158M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Norwest Venture Partners XI's Q2 2015 filing shows 1 new and 1 reduced positions. Its largest new stake was Apigee Corporation Common Stock: 472,557 shares worth $4.69M. The largest sale was Intersect ENT, Inc, an estimated $5.88M.
By sector, the portfolio is most concentrated in Technology at 60% of assets, up from 46% a quarter earlier.
- Norwest Venture Partners XI's largest Q2 2015 buy was Apigee Corporation Common Stock: 472,557 shares worth $4.69M.
- Norwest Venture Partners XI's biggest Q2 2015 reduction was Intersect ENT, Inc, cutting an estimated $5.88M.
- Norwest Venture Partners XI's ten largest holdings make up 100% of its $205M portfolio in Q2 2015.
- Norwest Venture Partners XI opened 1 new position and closed 0 in Q2 2015.
- Norwest Venture Partners XI's portfolio value rose 30% quarter-over-quarter to $205M.
Based on Norwest Venture Partners XI's 13F filing for Q2 2015, filed 28 Jul 2015.